Evidence map›Paper›PMID 41961379›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026

Protective role of VitC, Glutathione and Sodium Pyruvate against antibiotic-induced oxidative damage in Escherichia coli.

Anu Chauhan, Sarita Rana, Ritika Yadav, Dhanendra Kumar Rai, Nikhil Chand

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anu ChauhanDepartment of Life Sciences, Keral Verma Subharti College of Science, Swami Vivekanand Subharti University, Subhartipuram, NH-58, Delhi-Haridwar Bypass Road, Meerut, 250005, India. anuchauhan495@gmail.com.ORCID https://orcid.org/0000-0002-3367-5480
Sarita Rana *Department of Life Sciences, Keral Verma Subharti College of Science, Swami Vivekanand Subharti University, Subhartipuram, NH-58, Delhi-Haridwar Bypass Road, Meerut, 250005, India.
Ritika Yadav *Department of Life Sciences, Keral Verma Subharti College of Science, Swami Vivekanand Subharti University, Subhartipuram, NH-58, Delhi-Haridwar Bypass Road, Meerut, 250005, India.
Dhanendra Kumar RaiDepartment of Life Sciences, Keral Verma Subharti College of Science, Swami Vivekanand Subharti University, Subhartipuram, NH-58, Delhi-Haridwar Bypass Road, Meerut, 250005, India.
Nikhil ChandDepartment of Life Sciences, Keral Verma Subharti College of Science, Swami Vivekanand Subharti University, Subhartipuram, NH-58, Delhi-Haridwar Bypass Road, Meerut, 250005, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of antibiotic tolerance poses a significant challenge in the treatment of bacterial infections. This study investigates the inhibitory effects of commonly used antibiotics- Ciprofloxacin (CFX), Levofloxacin (LVX), and Ampcillin (Amp)-on exponentially growing Escherichia coli DH5α cells, and further explores the modulatory roles of antioxidants including Vitamin C(VitC), Glutathione, and Sodium pyruvate (Na-Pyr). Minimum inhibitory concentrations (MICs) were determined using the microplate Alamar Blue assay (MABA), revealing that fluoroquinolones (CFX and LVX) exhibited highest potency while Amp demonstrated moderate efficacy. Dose-dependent inhibition was observed for each antibiotic, with near-complete suppression of bacterial growth at higher concentrations. Interestingly, co-treatment with antioxidants significantly altered antibiotic performance. VitC enhanced the efficacy of CFX, LVX, and ampicillin. Glutathione increased the activity of CFX and also enhanced LVX and ampicillin efficacy, but primarily at lower concentrations. Na-Pyr showed minimal effect on CFX, while it increased the efficacy of LVX and Amp at lower concentrations. This suggests that these antioxidants may modulate redox homeostasis and amplify reactive oxygen species (ROS)-mediated stress, thereby boosting antibiotic lethality. Collectively, these findings highlight the contribution of oxidative stress to antibiotic action and suggest that co-treatment with specific antioxidants may serve as a promising strategy to improve therapeutic outcomes. This study adds to our understanding of exponentially growing cells susceptibility and antibiotic tolerance, revealing how metabolic and redox-modulating compounds can be leveraged to enhance bacterial killing.

Indexed as

Anti-Bacterial AgentsAntioxidantsAscorbic AcidEscherichia coliGlutathioneOxidative StressPyruvic AcidMicrobial Sensitivity TestsReactive Oxygen SpeciesAnti-Bacterial AgentsAntioxidantsAscorbic AcidGlutathionePyruvic AcidReactive Oxygen SpeciesCiprofloxacinE. coliGlutathioneLevofloxacin and AmpicillinSodium PyruvateVitamin C

Identifiers

PMID41961379
PMCPMC13069047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.